SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-20-004067
Filing Date
2020-05-29
Accepted
2020-05-29 08:15:29
Documents
12
Period of Report
2020-05-29
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_052920.htm   iXBRL 8-K 29949
  Complete submission text file 0001171843-20-004067.txt   207083

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE crvs-20200529.xsd EX-101.SCH 3162
3 XBRL LABEL FILE crvs-20200529_lab.xml EX-101.LAB 34591
4 XBRL PRESENTATION FILE crvs-20200529_pre.xml EX-101.PRE 22694
5 EXTRACTED XBRL INSTANCE DOCUMENT f8k_052920_htm.xml XML 3726
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37719 | Film No.: 20924086
SIC: 2834 Pharmaceutical Preparations